Gut Metabolite 2,8-Dihydroxyquinoline Shields Sperm Cells From Iron-Driven Cell Death

Male infertility is a growing global concern, and one of its most common culprits is a condition known as oligoasthenozoospermia, or OAS, in which a man produces too few sperm and the sperm that do exist swim poorly. For decades, treatment options for this condition have been limited, often relying on empirical antioxidant regimens whose mechanisms remain poorly understood. Now, a team of researchers at Shenzhen Bao’an Chinese Medicine Hospital, affiliated with Guangzhou University of Traditional Chinese Medicine, has reported a striking discovery: a small molecule called 2,8-dihydroxyquinoline, or 2,8-DHQ, can reverse key features of OAS in a mouse model by shutting down a specific molecular pathway that drives sperm-producing cells into a destructive form of cell death. The work, published in Molecular Biology Reports, offers both a mechanistic explanation for how a traditional herbal formula protects fertility and a candidate lead compound for future drug development.

The story begins with a clinical observation rather than a laboratory hypothesis. The researchers were interested in XianHuang Bushen Granules, a traditional Chinese medicine preparation that has been used to support male reproductive health, but whose active ingredients had never been clearly defined. To identify what in the formula might actually be doing the work, the team combined two complementary approaches: network pharmacology, a computational method that maps the interactions between drug components, their molecular targets, and disease-associated genes, and serum metabolomics, which uses mass spectrometry to catalog the small molecules circulating in the blood after treatment. When the two datasets were overlaid, one metabolite stood out. 2,8-DHQ, an endogenous antioxidant compound, shared 137 molecular targets with genes linked to oligoasthenozoospermia, making it the most plausible bioactive mediator of the formula’s effects on sperm production.

What makes 2,8-DHQ particularly intriguing is its origin. Previous work by other groups has shown that this quinoline derivative is not simply absorbed from plants but is synthesized by the gut microbiota, which produces it as a metabolite capable of activating the aryl hydrocarbon receptor, a cellular sensor involved in oxidative stress responses. In other words, the compound sits at the intersection of microbial metabolism, environmental signaling, and redox biology. The Shenzhen team’s findings now add male fertility to the list of physiological processes that this microbiota-derived molecule may influence, raising the possibility that the gut-reproductive axis plays a more direct role in spermatogenesis than previously appreciated.

To test whether 2,8-DHQ could actually treat OAS, the researchers first had to create the disease in laboratory animals. They chose BALB/c mice and administered glycosides of Tripterygium wilfordii, a plant extract known clinically as GTW, at a dose of 140 milligrams per kilogram per day for four weeks. GTW is used in medicine as an immunosuppressant, but one of its well-documented side effects is reproductive toxicity. As expected, the treated mice developed the hallmarks of OAS: their testes and epididymides shrank measurably, sperm concentration plummeted, serum testosterone dropped, and microscopic examination of the seminiferous tubules, the structures where sperm are manufactured, revealed severe architectural disruption. With the disease model established, the team then treated the animals for another four weeks with either the full herbal formula at three escalating doses or with purified 2,8-DHQ at 50 milligrams per kilogram per day.

The results were unambiguous. Mice receiving 2,8-DHQ recovered testicular weight, restored sperm counts, and regained near-normal testosterone levels, and their seminiferous tubules showed markedly improved histological structure compared with untreated OAS animals. The herbal formula produced similar benefits in a dose-dependent fashion, consistent with the idea that 2,8-DHQ is one of its principal active metabolites. But the researchers did not stop at observing organ-level recovery. They wanted to know exactly what the molecule was doing inside the cells that give rise to sperm, so they turned to GC-1 spermatogonia, a mouse cell line that models the spermatogonial stage of sperm development, and challenged the cells with hydrogen peroxide to mimic the oxidative assault that damages these cells in OAS.

The mechanistic core of the study centers on a form of regulated cell death called ferroptosis, a term coined in 2012 to describe an iron-dependent, lipid-peroxidation-driven demise that is distinct from apoptosis. In ferroptosis, iron catalyzes the destruction of polyunsaturated fatty acids in cell membranes, reactive oxygen species accumulate, and the cell’s antioxidant defenses, particularly the glutathione-dependent enzyme GPX4 and its membrane transporter partner SLC7A11, are overwhelmed. Spermatogonia are especially vulnerable to this process because they divide rapidly and carry membranes rich in the very fatty acids that ferroptosis consumes. The Shenzhen team found that in their OAS mice, the markers of ferroptosis were all elevated, and that 2,8-DHQ treatment reversed the entire signature: reactive oxygen species and malondialdehyde, a product of lipid peroxidation, went down; the ratio of reduced to oxidized glutathione, a standard measure of cellular antioxidant capacity, went up; and intracellular ferrous iron levels fell, alongside restored expression of SLC7A11 and GPX4.

The critical question was which molecular switch 2,8-DHQ was flipping to produce these effects. The answer came from a technique called Drug Affinity Responsive Target Stability, or DARTS, which exploits the fact that a small molecule bound to its protein target protects that protein from enzymatic digestion. Using DARTS, the researchers demonstrated that 2,8-DHQ binds directly to MAPK14, also known as p38 alpha, a mitogen-activated protein kinase with a long history in stress signaling. Western blot analysis confirmed that 2,8-DHQ treatment reduced MAPK14 protein levels in the stressed spermatogonia. This finding connects the study to a broader literature: MAPK14 has been implicated in driving ferroptosis in contexts ranging from sepsis-induced lung injury to hemorrhagic shock and inflammatory skin disease, suggesting that the kinase may be a general gatekeeper of the iron-dependent death program that 2,8-DHQ can now be shown to restrain in the testis.

Perhaps the most convincing element of the study is its use of a gain-of-function experiment to establish causation rather than mere correlation. When the researchers forced spermatogonia to overexpress MAPK14, the protective effects of 2,8-DHQ vanished, both in the cultured cells and, remarkably, in the living mice. Cells died despite the drug’s presence, oxidative stress markers climbed back up, and the improvements in sperm parameters were abolished. This kind of epistasis experiment, in which a downstream or parallel manipulation overrides a drug’s effect, is the gold standard for demonstrating that a drug acts through its proposed target. It strongly supports the authors’ conclusion that 2,8-DHQ ameliorates OAS specifically by inhibiting MAPK14-mediated ferroptosis in spermatogonia, rather than through some unrelated antioxidant activity.

The implications extend in several directions at once. For traditional Chinese medicine, the study provides a concrete molecular account of how a complex herbal formula can produce a reproducible physiological benefit, tracing the effect from a gut microbial metabolite through a specific kinase to a defined cell death program. For reproductive medicine, it identifies MAPK14 as a druggable node in the pathology of male infertility and offers 2,8-DHQ as a potential lead compound, though the authors and outside observers alike would caution that mouse models treated with experimentally induced toxicity are a long way from human clinical trials, and that dosing, safety, and pharmacokinetics in humans remain entirely untested. For the wider ferroptosis field, the work adds spermatogonia to the growing list of cell types whose fate hinges on the MAPK14 pathway, and it suggests that microbiota-derived quinolines may represent an untapped reservoir of natural ferroptosis inhibitors. The research was funded by the Shenzhen Bao’an Traditional Chinese Medicine Development Foundation and the Shenzhen Association of Chinese Medicine, and the animal experiments were conducted under institutional ethical approval following the ARRIVE guidelines. Whether 2,8-DHQ or derivatives of it will one day reach the fertility clinic is an open question, but the study has already changed the conversation by showing that a molecule made by gut bacteria can decide whether sperm-producing cells live or die.

Subject of Research: MAPK14-mediated spermatogonial ferroptosis in oligoasthenozoospermia and its inhibition by the metabolite 2,8-dihydroxyquinoline

Article Title: 2,8-Dihydroxyquinoline ameliorates oligoasthenozoospermia by inhibiting MAPK14-mediated spermatogonial ferroptosis

Article References: 2,8-Dihydroxyquinoline ameliorates oligoasthenozoospermia by inhibiting MAPK14-mediated spermatogonial ferroptosis. (n.d.). https://doi.org/10.1007/s11033-026-12786-8

Image Credits: AI Generated

DOI: 10.1007/s11033-026-12786-8

Keywords: oligoasthenozoospermia, 2,8-dihydroxyquinoline, ferroptosis, MAPK14, spermatogonia, oxidative stress, male infertility, gut microbiota metabolite, GPX4, SLC7A11, network pharmacology, metabolomics